Steven C. L. Ho

932 total citations
19 papers, 716 citations indexed

About

Steven C. L. Ho is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Steven C. L. Ho has authored 19 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Steven C. L. Ho's work include Viral Infectious Diseases and Gene Expression in Insects (15 papers), Virus-based gene therapy research (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Steven C. L. Ho is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (15 papers), Virus-based gene therapy research (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Steven C. L. Ho collaborates with scholars based in Singapore, France and Switzerland. Steven C. L. Ho's co-authors include Yuansheng Yang, Zhiwei Song, Muriel Bardor, Mariati, Yen Wah Tong, Miranda G.S. Yap, Jessna H. M. Yeo, Xuezhi Bi, Huatao Feng and Miranda G.S. Yap and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biotechnology and Bioengineering.

In The Last Decade

Steven C. L. Ho

19 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven C. L. Ho Singapore 15 602 264 231 129 57 19 716
Alexandre Regamey Switzerland 12 534 0.9× 276 1.0× 80 0.3× 74 0.6× 51 0.9× 18 602
Edmond M. Chan United States 5 546 0.9× 131 0.5× 96 0.4× 61 0.5× 43 0.8× 7 655
Yvette Stallwood United Kingdom 7 413 0.7× 277 1.0× 95 0.4× 146 1.1× 43 0.8× 8 543
Louis Bisson Canada 11 338 0.6× 107 0.4× 110 0.5× 43 0.3× 44 0.8× 15 440
Sarah Wulhfard Switzerland 14 534 0.9× 179 0.7× 360 1.6× 291 2.3× 61 1.1× 18 792
Dean O. Campbell United States 14 334 0.6× 89 0.3× 95 0.4× 172 1.3× 29 0.5× 19 610
Karl‐Heinz Scheidtmann Germany 11 515 0.9× 119 0.5× 51 0.2× 269 2.1× 36 0.6× 14 703
Jing‐Fang Lu United States 11 377 0.6× 79 0.3× 61 0.3× 135 1.0× 23 0.4× 20 620
S Nakagawa Japan 16 404 0.7× 188 0.7× 71 0.3× 236 1.8× 29 0.5× 26 702
Leontien Bosch Netherlands 14 364 0.6× 66 0.3× 200 0.9× 207 1.6× 17 0.3× 18 637

Countries citing papers authored by Steven C. L. Ho

Since Specialization
Citations

This map shows the geographic impact of Steven C. L. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven C. L. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven C. L. Ho more than expected).

Fields of papers citing papers by Steven C. L. Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven C. L. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven C. L. Ho. The network helps show where Steven C. L. Ho may publish in the future.

Co-authorship network of co-authors of Steven C. L. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Steven C. L. Ho. A scholar is included among the top collaborators of Steven C. L. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven C. L. Ho. Steven C. L. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Ho, Steven C. L., Jessna H. M. Yeo, Tianhua Wang, et al.. (2017). Impact of Signal Peptides on Furin‐2A Mediated Monoclonal Antibody Secretion in CHO Cells. Biotechnology Journal. 12(9). 24 indexed citations
3.
Ho, Steven C. L., et al.. (2016). Impact of hydrolysates on monoclonal antibody productivity, purification and quality in Chinese hamster ovary cells. Journal of Bioscience and Bioengineering. 122(4). 499–506. 16 indexed citations
4.
Ho, Steven C. L., et al.. (2016). Evaluating the use of a CpG free promoter for long-term recombinant protein expression stability in Chinese hamster ovary cells. BMC Biotechnology. 16(1). 71–71. 18 indexed citations
5.
Ho, Steven C. L., Yee Jiun Kok, Helen X. Pu, et al.. (2015). Optimization of Heavy Chain and Light Chain Signal Peptides for High Level Expression of Therapeutic Antibodies in CHO Cells. PLoS ONE. 10(2). e0116878–e0116878. 87 indexed citations
6.
Ho, Steven C. L., Tianhua Wang, Zhiwei Song, & Yuansheng Yang. (2015). IgG Aggregation Mechanism for CHO Cell Lines Expressing Excess Heavy Chains. Molecular Biotechnology. 57(7). 625–634. 10 indexed citations
7.
8.
Yeo, Jessna H. M., et al.. (2014). Insertion of core CpG island element into human CMV promoter for enhancing recombinant protein expression stability in CHO cells. Biotechnology Progress. 30(3). 523–534. 23 indexed citations
9.
Ho, Steven C. L. & Yuansheng Yang. (2014). Identifying and engineering promoters for high level and sustainable therapeutic recombinant protein production in cultured mammalian cells. Biotechnology Letters. 36(8). 1569–1579. 17 indexed citations
10.
Ho, Steven C. L., Muriel Bardor, Bin Li, et al.. (2013). Comparison of Internal Ribosome Entry Site (IRES) and Furin-2A (F2A) for Monoclonal Antibody Expression Level and Quality in CHO Cells. PLoS ONE. 8(5). e63247–e63247. 54 indexed citations
11.
Ho, Steven C. L., Monika Mueller, Corrine Wan, et al.. (2013). Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability. Journal of Biotechnology. 165(3-4). 157–166. 71 indexed citations
12.
Ho, Steven C. L., et al.. (2013). An Internal Ribosome Entry Site (IRES) Mutant Library for Tuning Expression Level of Multiple Genes in Mammalian Cells. PLoS ONE. 8(12). e82100–e82100. 43 indexed citations
13.
Ho, Steven C. L., Muriel Bardor, Huatao Feng, et al.. (2011). IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines. Journal of Biotechnology. 157(1). 130–139. 117 indexed citations
14.
Ho, Steven C. L., et al.. (2011). Post-transcriptional Regulatory Elements for Enhancing Transient Gene Expression Levels in Mammalian Cells. Methods in molecular biology. 801. 125–135. 9 indexed citations
15.
Ho, Steven C. L., et al.. (2009). Evaluating post-transcriptional regulatory elements for enhancing transient gene expression levels in CHO K1 and HEK293 cells. Protein Expression and Purification. 69(1). 9–15. 41 indexed citations
16.
Yang, Yuansheng, Mariati, Steven C. L. Ho, & Miranda G.S. Yap. (2008). Mutated polyadenylation signals for controlling expression levels of multiple genes in mammalian cells. Biotechnology and Bioengineering. 102(4). 1152–1160. 24 indexed citations
17.
Miller, William R., Alexey A. Larionov, Lorna Renshaw, et al.. (2007). Aromatase inhibitors—Gene discovery. The Journal of Steroid Biochemistry and Molecular Biology. 106(1-5). 130–142. 18 indexed citations
18.
Miller, William R., Alexey A. Larionov, Lorna Renshaw, et al.. (2007). Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole. Pharmacogenetics and Genomics. 17(10). 813–826. 83 indexed citations
19.
Miller, W.R., Lorna Renshaw, Alexey A. Larionov, et al.. (2005). Prediction of hormone response in breast cancer by microarray analysis of sequential tumour biopsies from patients receiving neoadjuvant therapy with letrozole. Journal of Clinical Oncology. 23(16_suppl). 3025–3025. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026